biotech stock review

Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’ Smear Test Screening.

DALRADA aims to introduce its VIA Test kit to females in India - of which there is 497 million.
Internet Stock Review

And it’s Official. We Have Another Double. BioSig (BSGM) up 103% in Four Months.

This is crazy. Wish we were 'traders' but sadly we are not. This is the most fun we've had since 1998, pre-dotcom...
Hapbee

Augmentative Wearable Device, Hapbee, Receives Amazing Reviews by Testers.

Originally posted on MartechSeries. The innovative augmentative wearable device, Hapbee, has been giving testers a reason to be happy....
Hepion Pharma HEPA

News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.

Of course, approval news is the ultimate "as huge as it gets" news. But at this stage...
aPHEX bIOcLEANSE

Hy-IQ Trademark

REGISTERED 9-15-2020

ABVC BioPharma (ABVC) Approved for ABV-1505 Phase II Part II in Taiwan Sites

Gentleman, Start Your Engines? ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study

Institutional Analyst, Weekly Newsletter.

- Telehealth Watch List- 2021 Psychedelic Investor Guide out Wednesday.- Report: Ehave Inc (EHVVF) Our Favorite Small Psychedelic Company- Ehave (EHVVF) Announces Inclusion...
@NCI

Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in Stem Cell and...

- Addition of leading scholar and KOL in acute respiratory distress syndrome (ARDS) to ARDS Scientific Advisory Board supports continued progress of...
Immunomedics IMMU, Biotech Stock Review

Immunomedics (IMMU) up 100% Today or $2 Billion in Value.

Again as mentioned a few weeks ago, our bearish market opinion is related to large-caps and large-cap funds and ETF's. If...

Report: Is Psycheceutical BioScience (BWVI) One of the Most Important Companies in the Psychedelic...

Initiating Coverage on Psycheceutical BioScience (BWVI). "Imagine Applying a Psychedelic Topically, Receiving the Benefits...

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!